New York, NY, United States of America

Robert O'Neill


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 70(Granted Patents)


Location History:

  • New York, NY (US) (1998 - 2009)
  • Yonkers, NY (US) (2009)

Company Filing History:


Years Active: 1998-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Robert O'Neill - Pioneering Antiviral Compounds in New York, NY

Introduction:

Robert O'Neill, a distinguished inventor hailing from New York, NY, has made significant contributions in the field of antiviral compounds. With a total of 5 patents to his name, O'Neill's work focuses on identifying host cell proteins that interact with viral proteins crucial for viral replication, thereby paving the way for innovative therapeutic interventions.

Latest Patents:

O'Neill's groundbreaking inventions revolve around the identification and utilization of antiviral compounds that disrupt the interaction between host cell proteins and viral proteins necessary for viral propagation. One of his recent patents involves uncovering novel interactions between influenza virus proteins and human host cell proteins, leading to the development of compounds that impede viral replication and hold promise in the treatment of viral infections.

Career Highlights:

Having traversed the corridors of innovation, Robert O'Neill has left an indelible mark at prestigious institutions such as Mount Sinai School of Medicine of New York University and The Mount Sinai Medical Center. His diligent research and inventive spirit have been instrumental in advancing the field of antiviral therapeutics.

Collaborations:

Throughout his illustrious career, O'Neill has had the privilege of collaborating with esteemed professionals in the field, including prominent figures like Peter M Palese and Ronald N Harty. Together, they have synergized their expertise to propel forward cutting-edge research in antiviral compounds and viral-host interactions.

Conclusion:

In conclusion, Robert O'Neill stands as a beacon of innovation in the realm of antiviral research, with his inventive prowess underscoring the importance of disrupting viral replication mechanisms for therapeutic benefits. His patents and collaborations exemplify his dedication to tackling viral infections through novel approaches, making him a trailblazer in the field of antiviral pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…